Abingworth leans into company creation with largest-ever fund at $465M

Strong performance and continued broad interest in life sciences led to Abingworth raising its largest-ever fund, with the trans-Atlantic VC putting more energy into company creation and co-development deals.

On Wednesday, Abingworth announced the closing of Abingworth Bioventures 8 at its hard cap of $465 million, exceeding its target of $375 million. The firm is the latest in a string of Europe-focused VCs to raise its largest fund yet...